HPS6
Basic information
Region (hg38): 10:102065349-102068036
Links
Phenotypes
GenCC
Source:
- Hermansky-Pudlak syndrome 6 (Strong), mode of inheritance: AR
- Hermansky-Pudlak syndrome without pulmonary fibrosis (Supportive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 6 (Definitive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 6 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hermansky-Pudlak syndrome 6 | AR | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic | Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPS | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary | 12548288; 20301464; 27225848 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (53 variants)
- Hermansky-Pudlak syndrome 6 (11 variants)
- Hermansky-Pudlak syndrome (5 variants)
- HPS6-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPS6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 170 | 188 | |||
missense | 215 | 227 | ||||
nonsense | 21 | 29 | ||||
start loss | 1 | |||||
frameshift | 33 | 12 | 47 | |||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 55 | 22 | 233 | 178 | 9 |
Highest pathogenic variant AF is 0.0000525
Variants in HPS6
This is a list of pathogenic ClinVar variants found in the HPS6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-102065470-G-A | Hermansky-Pudlak syndrome 6 • not specified • HPS6-related disorder | Uncertain significance (Jun 10, 2020) | ||
10-102065475-A-G | Hermansky-Pudlak syndrome 6 | Uncertain significance (Apr 01, 2022) | ||
10-102065478-A-T | Pathogenic (Jun 09, 2023) | |||
10-102065481-C-T | Hermansky-Pudlak syndrome 6 | Uncertain significance (Aug 23, 2022) | ||
10-102065485-C-T | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
10-102065487-G-A | Uncertain significance (Jul 29, 2022) | |||
10-102065489-G-A | Likely benign (Sep 21, 2023) | |||
10-102065490-ACT-A | Hermansky-Pudlak syndrome 6 | Likely pathogenic (Dec 30, 2017) | ||
10-102065491-C-T | Uncertain significance (Aug 01, 2022) | |||
10-102065498-G-T | Likely benign (May 19, 2023) | |||
10-102065500-TG-T | Pathogenic (Nov 05, 2023) | |||
10-102065504-C-G | HPS6-related disorder | Likely benign (Jan 11, 2024) | ||
10-102065504-C-T | Likely benign (Apr 14, 2023) | |||
10-102065507-G-A | Likely benign (Mar 27, 2023) | |||
10-102065511-CT-GG | Uncertain significance (Oct 24, 2022) | |||
10-102065516-C-T | Likely benign (Jan 03, 2024) | |||
10-102065517-G-A | Uncertain significance (May 06, 2021) | |||
10-102065518-C-G | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
10-102065518-C-T | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
10-102065519-C-T | Likely benign (Aug 02, 2023) | |||
10-102065521-T-C | Uncertain significance (Jan 15, 2022) | |||
10-102065523-G-GGCGGC | Hermansky-Pudlak syndrome • HPS6-related disorder | Pathogenic (Jan 24, 2024) | ||
10-102065528-C-T | Likely benign (Nov 19, 2023) | |||
10-102065531-G-A | Likely benign (Dec 09, 2023) | |||
10-102065544-G-A | Inborn genetic diseases | Uncertain significance (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HPS6 | protein_coding | protein_coding | ENST00000299238 | 1 | 2646 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000277 | 0.997 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0257 | 404 | 403 | 1.00 | 0.0000235 | 4748 |
Missense in Polyphen | 108 | 127.6 | 0.84639 | 1637 | ||
Synonymous | -1.65 | 220 | 191 | 1.15 | 0.0000103 | 1880 |
Loss of Function | 2.61 | 10 | 23.7 | 0.421 | 0.00000160 | 209 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May regulate the synthesis and function of lysosomes and of highly specialized organelles, such as melanosomes and platelet dense granules (PubMed:17041891). Acts as cargo adapter for the dynein-dynactin motor complex to mediate the transport of lysosomes from the cell periphery to the perinuclear region. Facilitates retrograde lysosomal trafficking by linking the motor complex to lysosomes, and perinuclear positioning of lysosomes is crucial for the delivery of endocytic cargos to lysosomes, for lysosome maturation and functioning (PubMed:25189619). {ECO:0000269|PubMed:17041891, ECO:0000269|PubMed:25189619}.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.341
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.71
Haploinsufficiency Scores
- pHI
- 0.101
- hipred
- Y
- hipred_score
- 0.520
- ghis
- 0.644
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hps6
- Phenotype
- immune system phenotype; renal/urinary system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- organelle organization;blood coagulation;melanocyte differentiation;lysosome localization;protein localization to membrane
- Cellular component
- lysosomal membrane;endoplasmic reticulum;membrane;BLOC-2 complex;early endosome membrane
- Molecular function
- protein binding;Rab GTPase binding;GTP-dependent protein binding